Total planned funding: $237,414,706
Clear active filters
Mozambique
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $237,414,706 |
Organizational Types
Private Contractor | $235,412,502 |
Own Agency | $1,741,196 |
Unknown | $214,046 |
Other USG Agency | $46,962 |
Host Country Government Agency | $0 |
University | $0 |
NGO | $0 |
Implementing Agency | $0 |
Multi-lateral Agency | $0 |
FBO | $0 |
Program Areas
Treatment | $237,414,706 |
Budget Codes
HTXD: Treatment: ARV Drugs | $237,414,706 |
Top Partner Programs
Chemonics International:
$81,637,507
Countries/Regions
Mozambique
2016 | $31,500,000 |
2018 | $24,187,059 |
2019 | $25,950,448 |
U.S. Agency for International Development:
$635,425
Countries/Regions
Mozambique
2013 | $119,878 |
2014 | $249,466 |
2019 | $266,081 |
U.S. Centers for Disease Control and Prevention:
$391,069
Countries/Regions
Mozambique
2008 | $123,247 |
2013 | $92,433 |
2014 | $167,328 |
2019 | $8,061 |